The role of HER2 as a therapeutic biomarker in gynaecological malignancy: potential for use beyond uterine serous carcinoma
Karen L. Talia, Natalie Banet, Natália Buza
Topics & Concepts
MedicineSerous fluidTargeted therapyOncologyBiomarkerContext (archaeology)MalignancyInternal medicineSerous carcinomaCarcinomaCancer researchCancerOvarian cancerBiologyBiochemistryPaleontologyHER2/EGFR in Cancer ResearchCancer and Skin LesionsPeptidase Inhibition and Analysis